SPONSOR
AC Camargo Cancer Center
Total Trials
2
Recruiting
2
Phases
Phase 2
Conditions studied: Colon CancerOxaliplatin-induced Peripheral NeuropathyRectal Cancer, Adenocarcinoma
AC Camargo Cancer Center is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Colon Cancer, Oxaliplatin-induced Peripheral Neuropathy, Rectal Cancer, Adenocarcinoma.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — AC Camargo Cancer Center
How many clinical trials has AC Camargo Cancer Center sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by AC Camargo Cancer Center, of which 2 are actively recruiting participants. These trials cover conditions including Colon Cancer, Oxaliplatin-induced Peripheral Neuropathy, Rectal Cancer, Adenocarcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does AC Camargo Cancer Center research focus on?
AC Camargo Cancer Center clinical trials span Colon Cancer, Oxaliplatin-induced Peripheral Neuropathy, Rectal Cancer, Adenocarcinoma. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a AC Camargo Cancer Center clinical trial?
To participate in a AC Camargo Cancer Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all AC Camargo Cancer Center trials with current recruitment status updated daily.
Clinical Trials by AC Camargo Cancer Center
NCT07285356
Recruiting
Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy
Colon Cancer
NCT06793137 Phase 2
Recruiting
Intestinal Microbiome Modulation With Antibiotics in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Rectal Cancer, Adenocarcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology